The Department of Energy’s semiautonomous National Nuclear Security Administration has awarded $10 million in Phase II funding to SHINE Medical Technologies as part of the agency’s program to promote a domestic supply of molybdenum-99 (mo-99).
The…
SUBSCRIBER ACCESS
Thank you for visiting
Nuclear Security & Deterrence Monitor!
You must be logged in as a subscriber to view this page.









